nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—SLC6A3—malignant glioma	0.626	1	CbGaD
Dopamine—DRD3—telencephalic ventricle—malignant glioma	0.00864	0.0604	CbGeAlD
Dopamine—POU5F1—cerebellum—malignant glioma	0.00742	0.0519	CbGeAlD
Dopamine—DRD1—telencephalic ventricle—malignant glioma	0.00619	0.0433	CbGeAlD
Dopamine—COMT—telencephalic ventricle—malignant glioma	0.00557	0.0389	CbGeAlD
Dopamine—SLC6A3—telencephalic ventricle—malignant glioma	0.00497	0.0348	CbGeAlD
Dopamine—HTR7—pons—malignant glioma	0.0047	0.0329	CbGeAlD
Dopamine—HTR1A—telencephalic ventricle—malignant glioma	0.00405	0.0283	CbGeAlD
Dopamine—HTR7—telencephalic ventricle—malignant glioma	0.00387	0.027	CbGeAlD
Dopamine—DRD2—telencephalic ventricle—malignant glioma	0.00366	0.0256	CbGeAlD
Dopamine—DBH—brainstem—malignant glioma	0.00285	0.0199	CbGeAlD
Dopamine—DBH—telencephalon—malignant glioma	0.00253	0.0177	CbGeAlD
Dopamine—HTR7—endothelium—malignant glioma	0.00208	0.0145	CbGeAlD
Dopamine—DBH—medulla oblongata—malignant glioma	0.00199	0.0139	CbGeAlD
Dopamine—DRD5—telencephalon—malignant glioma	0.00194	0.0136	CbGeAlD
Dopamine—HTR7—blood vessel—malignant glioma	0.00191	0.0134	CbGeAlD
Dopamine—DRD1—brainstem—malignant glioma	0.00167	0.0117	CbGeAlD
Dopamine—COMT—brainstem—malignant glioma	0.00151	0.0105	CbGeAlD
Dopamine—DRD1—telencephalon—malignant glioma	0.00149	0.0104	CbGeAlD
Dopamine—DBH—central nervous system—malignant glioma	0.00144	0.0101	CbGeAlD
Dopamine—DBH—cerebellum—malignant glioma	0.00141	0.00983	CbGeAlD
Dopamine—SLC22A3—embryo—malignant glioma	0.00138	0.00967	CbGeAlD
Dopamine—SLC6A3—brainstem—malignant glioma	0.00135	0.00941	CbGeAlD
Dopamine—COMT—telencephalon—malignant glioma	0.00134	0.00935	CbGeAlD
Dopamine—DRD4—brain—malignant glioma	0.00133	0.00932	CbGeAlD
Dopamine—MAOB—embryo—malignant glioma	0.00128	0.00895	CbGeAlD
Dopamine—SLC6A4—brainstem—malignant glioma	0.00123	0.00862	CbGeAlD
Dopamine—SLC6A3—telencephalon—malignant glioma	0.00119	0.00835	CbGeAlD
Dopamine—DRD3—central nervous system—malignant glioma	0.00118	0.00825	CbGeAlD
Dopamine—SLC22A1—telencephalon—malignant glioma	0.00118	0.00823	CbGeAlD
Dopamine—MAOB—brainstem—malignant glioma	0.00117	0.0082	CbGeAlD
Dopamine—Mesalazine—PPARG—malignant glioma	0.00117	0.374	CrCbGaD
Dopamine—DBH—brain—malignant glioma	0.00114	0.00798	CbGeAlD
Dopamine—ADRB1—telencephalon—malignant glioma	0.00113	0.00792	CbGeAlD
Dopamine—DRD5—central nervous system—malignant glioma	0.00111	0.00773	CbGeAlD
Dopamine—HTR1A—brainstem—malignant glioma	0.00109	0.00766	CbGeAlD
Dopamine—SLC6A4—telencephalon—malignant glioma	0.00109	0.00765	CbGeAlD
Dopamine—MAOA—embryo—malignant glioma	0.00109	0.00763	CbGeAlD
Dopamine—SLC6A2—brainstem—malignant glioma	0.00109	0.00759	CbGeAlD
Dopamine—DRD1—midbrain—malignant glioma	0.00107	0.00746	CbGeAlD
Dopamine—COMT—medulla oblongata—malignant glioma	0.00105	0.00735	CbGeAlD
Dopamine—HTR7—brainstem—malignant glioma	0.00105	0.00732	CbGeAlD
Dopamine—MAOB—telencephalon—malignant glioma	0.00104	0.00728	CbGeAlD
Dopamine—MAOA—brainstem—malignant glioma	0.001	0.00699	CbGeAlD
Dopamine—DRD2—brainstem—malignant glioma	0.000989	0.00692	CbGeAlD
Dopamine—HTR1A—telencephalon—malignant glioma	0.000972	0.00679	CbGeAlD
Dopamine—MAOA—retina—malignant glioma	0.000965	0.00675	CbGeAlD
Dopamine—SLC6A2—telencephalon—malignant glioma	0.000963	0.00674	CbGeAlD
Dopamine—COMT—midbrain—malignant glioma	0.00096	0.00672	CbGeAlD
Dopamine—DRD2—retina—malignant glioma	0.000954	0.00667	CbGeAlD
Dopamine—COMT—spinal cord—malignant glioma	0.000937	0.00655	CbGeAlD
Dopamine—DRD3—brain—malignant glioma	0.000936	0.00655	CbGeAlD
Dopamine—HTR7—telencephalon—malignant glioma	0.000929	0.00649	CbGeAlD
Dopamine—SLC22A5—retina—malignant glioma	0.000889	0.00621	CbGeAlD
Dopamine—MAOA—telencephalon—malignant glioma	0.000888	0.00621	CbGeAlD
Dopamine—DRD2—telencephalon—malignant glioma	0.000878	0.00614	CbGeAlD
Dopamine—DRD5—brain—malignant glioma	0.000878	0.00614	CbGeAlD
Dopamine—Mesalazine—PTGS1—malignant glioma	0.000863	0.276	CrCbGaD
Dopamine—SLC6A3—midbrain—malignant glioma	0.000858	0.006	CbGeAlD
Dopamine—DRD1—central nervous system—malignant glioma	0.000845	0.00591	CbGeAlD
Dopamine—SLC6A3—spinal cord—malignant glioma	0.000837	0.00585	CbGeAlD
Dopamine—MAOB—medulla oblongata—malignant glioma	0.000817	0.00572	CbGeAlD
Dopamine—SLC6A4—midbrain—malignant glioma	0.000786	0.0055	CbGeAlD
Dopamine—SLC6A4—spinal cord—malignant glioma	0.000767	0.00536	CbGeAlD
Dopamine—COMT—central nervous system—malignant glioma	0.00076	0.00532	CbGeAlD
Dopamine—SLC6A2—medulla oblongata—malignant glioma	0.000757	0.00529	CbGeAlD
Dopamine—MAOB—midbrain—malignant glioma	0.000747	0.00522	CbGeAlD
Dopamine—COMT—cerebellum—malignant glioma	0.000743	0.0052	CbGeAlD
Dopamine—HTR7—medulla oblongata—malignant glioma	0.00073	0.0051	CbGeAlD
Dopamine—MAOB—spinal cord—malignant glioma	0.000729	0.0051	CbGeAlD
Dopamine—HTR1A—midbrain—malignant glioma	0.000698	0.00488	CbGeAlD
Dopamine—MAOA—medulla oblongata—malignant glioma	0.000697	0.00488	CbGeAlD
Dopamine—HTR1A—spinal cord—malignant glioma	0.000681	0.00476	CbGeAlD
Dopamine—SLC6A3—central nervous system—malignant glioma	0.000679	0.00475	CbGeAlD
Dopamine—DRD1—brain—malignant glioma	0.000671	0.00469	CbGeAlD
Dopamine—SLC22A1—central nervous system—malignant glioma	0.000669	0.00468	CbGeAlD
Dopamine—HTR7—midbrain—malignant glioma	0.000667	0.00466	CbGeAlD
Dopamine—SLC6A3—cerebellum—malignant glioma	0.000663	0.00464	CbGeAlD
Dopamine—HTR7—spinal cord—malignant glioma	0.000651	0.00455	CbGeAlD
Dopamine—ADRB1—central nervous system—malignant glioma	0.000644	0.0045	CbGeAlD
Dopamine—SLC22A5—medulla oblongata—malignant glioma	0.000642	0.00449	CbGeAlD
Dopamine—SLC22A3—central nervous system—malignant glioma	0.000639	0.00447	CbGeAlD
Dopamine—MAOA—midbrain—malignant glioma	0.000637	0.00446	CbGeAlD
Dopamine—DRD2—midbrain—malignant glioma	0.00063	0.00441	CbGeAlD
Dopamine—SLC6A4—central nervous system—malignant glioma	0.000622	0.00435	CbGeAlD
Dopamine—MAOA—spinal cord—malignant glioma	0.000622	0.00435	CbGeAlD
Dopamine—COMT—brain—malignant glioma	0.000603	0.00422	CbGeAlD
Dopamine—Epinephrine—TNF—malignant glioma	0.000598	0.192	CrCbGaD
Dopamine—CYP2D6—brainstem—malignant glioma	0.000594	0.00416	CbGeAlD
Dopamine—MAOB—central nervous system—malignant glioma	0.000591	0.00414	CbGeAlD
Dopamine—SLC22A5—midbrain—malignant glioma	0.000587	0.00411	CbGeAlD
Dopamine—MAOB—cerebellum—malignant glioma	0.000578	0.00404	CbGeAlD
Dopamine—SLC22A5—spinal cord—malignant glioma	0.000573	0.00401	CbGeAlD
Dopamine—HTR1A—central nervous system—malignant glioma	0.000552	0.00386	CbGeAlD
Dopamine—SLC6A2—central nervous system—malignant glioma	0.000548	0.00383	CbGeAlD
Dopamine—HTR1A—cerebellum—malignant glioma	0.00054	0.00377	CbGeAlD
Dopamine—SLC6A3—brain—malignant glioma	0.000539	0.00377	CbGeAlD
Dopamine—SLC22A1—brain—malignant glioma	0.000531	0.00371	CbGeAlD
Dopamine—HTR7—central nervous system—malignant glioma	0.000528	0.00369	CbGeAlD
Dopamine—CYP2D6—telencephalon—malignant glioma	0.000528	0.00369	CbGeAlD
Dopamine—HTR7—cerebellum—malignant glioma	0.000516	0.00361	CbGeAlD
Dopamine—ADRB1—brain—malignant glioma	0.000511	0.00357	CbGeAlD
Dopamine—SLC22A3—brain—malignant glioma	0.000507	0.00355	CbGeAlD
Dopamine—MAOA—central nervous system—malignant glioma	0.000505	0.00353	CbGeAlD
Dopamine—DRD2—central nervous system—malignant glioma	0.000499	0.00349	CbGeAlD
Dopamine—SLC6A4—brain—malignant glioma	0.000494	0.00345	CbGeAlD
Dopamine—MAOA—cerebellum—malignant glioma	0.000493	0.00345	CbGeAlD
Dopamine—Mesalazine—PTGS2—malignant glioma	0.000493	0.158	CrCbGaD
Dopamine—DRD2—cerebellum—malignant glioma	0.000488	0.00341	CbGeAlD
Dopamine—MAOB—brain—malignant glioma	0.000469	0.00328	CbGeAlD
Dopamine—SLC22A5—cerebellum—malignant glioma	0.000454	0.00318	CbGeAlD
Dopamine—HTR1A—brain—malignant glioma	0.000438	0.00307	CbGeAlD
Dopamine—SLC6A2—brain—malignant glioma	0.000435	0.00304	CbGeAlD
Dopamine—HTR7—brain—malignant glioma	0.000419	0.00293	CbGeAlD
Dopamine—MAOA—brain—malignant glioma	0.000401	0.0028	CbGeAlD
Dopamine—DRD2—brain—malignant glioma	0.000396	0.00277	CbGeAlD
Dopamine—SLC22A5—brain—malignant glioma	0.000369	0.00258	CbGeAlD
Dopamine—CYP2D6—central nervous system—malignant glioma	0.0003	0.0021	CbGeAlD
Dopamine—CYP2D6—cerebellum—malignant glioma	0.000293	0.00205	CbGeAlD
Dopamine—CYP2D6—brain—malignant glioma	0.000238	0.00166	CbGeAlD
Dopamine—HTR7—Signaling Pathways—CXCL8—malignant glioma	8.68e-06	3.81e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.65e-06	3.8e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PIK3CB—malignant glioma	8.65e-06	3.8e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EGF—malignant glioma	8.63e-06	3.79e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—KRAS—malignant glioma	8.63e-06	3.79e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—BRAF—malignant glioma	8.58e-06	3.77e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PTPN11—malignant glioma	8.58e-06	3.77e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—FGF2—malignant glioma	8.55e-06	3.75e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GSTP1—malignant glioma	8.52e-06	3.74e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PIK3CD—malignant glioma	8.51e-06	3.74e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—FGF2—malignant glioma	8.44e-06	3.7e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CAV1—malignant glioma	8.42e-06	3.7e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—MYC—malignant glioma	8.41e-06	3.69e-05	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—AKT1—malignant glioma	8.38e-06	3.68e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—AKT2—malignant glioma	8.35e-06	3.67e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—BCHE—malignant glioma	8.35e-06	3.66e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—KDR—malignant glioma	8.32e-06	3.65e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—EGFR—malignant glioma	8.32e-06	3.65e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CXCL8—malignant glioma	8.31e-06	3.65e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CASP3—malignant glioma	8.31e-06	3.65e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CAT—malignant glioma	8.29e-06	3.64e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL2—malignant glioma	8.29e-06	3.64e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—SLC5A5—malignant glioma	8.25e-06	3.62e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—EGFR—malignant glioma	8.23e-06	3.61e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—BRAF—malignant glioma	8.21e-06	3.6e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PTEN—malignant glioma	8.14e-06	3.57e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—PIK3CA—malignant glioma	8.03e-06	3.53e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PIK3CD—malignant glioma	8.03e-06	3.52e-05	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—AKT1—malignant glioma	8.03e-06	3.52e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—F2—malignant glioma	8.01e-06	3.52e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—FN1—malignant glioma	8.01e-06	3.52e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MDM2—malignant glioma	8e-06	3.51e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—AKT2—malignant glioma	7.99e-06	3.51e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—RAF1—malignant glioma	7.97e-06	3.5e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PIK3CB—malignant glioma	7.96e-06	3.5e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—EGFR—malignant glioma	7.96e-06	3.49e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CASP3—malignant glioma	7.95e-06	3.49e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—PIK3CA—malignant glioma	7.95e-06	3.49e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL2—malignant glioma	7.94e-06	3.49e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—PIK3CA—malignant glioma	7.92e-06	3.48e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—BAD—malignant glioma	7.92e-06	3.48e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MDM2—malignant glioma	7.89e-06	3.47e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PTGS2—malignant glioma	7.89e-06	3.46e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—ERBB2—malignant glioma	7.89e-06	3.46e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.88e-06	3.46e-05	CbGpPWpGaD
Dopamine—COMT—Metabolism—AKT1—malignant glioma	7.88e-06	3.46e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—RAF1—malignant glioma	7.87e-06	3.45e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—KRAS—malignant glioma	7.86e-06	3.45e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MMP9—malignant glioma	7.85e-06	3.45e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NOTCH1—malignant glioma	7.84e-06	3.44e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GSTP1—malignant glioma	7.84e-06	3.44e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—NCOR1—malignant glioma	7.83e-06	3.44e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—PTEN—malignant glioma	7.8e-06	3.43e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.8e-06	3.42e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PIK3CB—malignant glioma	7.78e-06	3.42e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—ERBB2—malignant glioma	7.78e-06	3.42e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—KRAS—malignant glioma	7.77e-06	3.41e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GSTP1—malignant glioma	7.77e-06	3.41e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—PIK3CA—malignant glioma	7.74e-06	3.4e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.73e-06	3.39e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—FGF2—malignant glioma	7.69e-06	3.37e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CD80—malignant glioma	7.68e-06	3.37e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PIK3CB—malignant glioma	7.68e-06	3.37e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PIK3CD—malignant glioma	7.68e-06	3.37e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CG—malignant glioma	7.67e-06	3.37e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—APC—malignant glioma	7.67e-06	3.37e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CAT—malignant glioma	7.63e-06	3.35e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—AKT1—malignant glioma	7.61e-06	3.34e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—PIK3CA—malignant glioma	7.61e-06	3.34e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EGF—malignant glioma	7.58e-06	3.33e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CAT—malignant glioma	7.56e-06	3.32e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PTPN11—malignant glioma	7.53e-06	3.31e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—KRAS—malignant glioma	7.52e-06	3.3e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MMP9—malignant glioma	7.51e-06	3.3e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CXCL8—malignant glioma	7.48e-06	3.28e-05	CbGpPWpGaD
Dopamine—MAOB—Metabolism—AKT1—malignant glioma	7.47e-06	3.28e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PTEN—malignant glioma	7.47e-06	3.28e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PIK3CB—malignant glioma	7.42e-06	3.26e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CXCL8—malignant glioma	7.38e-06	3.24e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PTGS2—malignant glioma	7.35e-06	3.23e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—FGF2—malignant glioma	7.35e-06	3.23e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—AKT1—malignant glioma	7.29e-06	3.2e-05	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—AKT1—malignant glioma	7.22e-06	3.17e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—PIK3CA—malignant glioma	7.22e-06	3.17e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—BRAF—malignant glioma	7.21e-06	3.16e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—NCOR1—malignant glioma	7.2e-06	3.16e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MDM2—malignant glioma	7.19e-06	3.16e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—RAF1—malignant glioma	7.17e-06	3.15e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CASP3—malignant glioma	7.16e-06	3.14e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL2—malignant glioma	7.15e-06	3.14e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—NCOR1—malignant glioma	7.14e-06	3.14e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—PIK3CA—malignant glioma	7.14e-06	3.13e-05	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—AKT1—malignant glioma	7.13e-06	3.13e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ERBB2—malignant glioma	7.09e-06	3.11e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CASP3—malignant glioma	7.06e-06	3.1e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL2—malignant glioma	7.05e-06	3.1e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—VEGFA—malignant glioma	7.05e-06	3.09e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—AKT2—malignant glioma	7.02e-06	3.08e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PIK3CB—malignant glioma	7e-06	3.07e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—EGFR—malignant glioma	6.99e-06	3.07e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—STAT3—malignant glioma	6.98e-06	3.06e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—malignant glioma	6.91e-06	3.03e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—PIK3CA—malignant glioma	6.91e-06	3.03e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PTEN—malignant glioma	6.88e-06	3.02e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MDM2—malignant glioma	6.88e-06	3.02e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—RAF1—malignant glioma	6.85e-06	3.01e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ERBB2—malignant glioma	6.78e-06	2.98e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MMP9—malignant glioma	6.76e-06	2.97e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—VEGFA—malignant glioma	6.75e-06	2.96e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CD—malignant glioma	6.74e-06	2.96e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.74e-06	2.96e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PTEN—malignant glioma	6.73e-06	2.95e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CXCL8—malignant glioma	6.72e-06	2.95e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PIK3CB—malignant glioma	6.69e-06	2.94e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—STAT3—malignant glioma	6.68e-06	2.93e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	6.68e-06	2.93e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MMP9—malignant glioma	6.67e-06	2.93e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GSTP1—malignant glioma	6.64e-06	2.92e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PTEN—malignant glioma	6.64e-06	2.91e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—KRAS—malignant glioma	6.6e-06	2.9e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—AKT1—malignant glioma	6.56e-06	2.88e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—AKT1—malignant glioma	6.5e-06	2.85e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MYC—malignant glioma	6.49e-06	2.85e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—AKT1—malignant glioma	6.47e-06	2.84e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CAT—malignant glioma	6.46e-06	2.84e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—FGF2—malignant glioma	6.45e-06	2.83e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CASP3—malignant glioma	6.44e-06	2.83e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CXCL8—malignant glioma	6.43e-06	2.82e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL2—malignant glioma	6.43e-06	2.82e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PTEN—malignant glioma	6.41e-06	2.82e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CAV1—malignant glioma	6.39e-06	2.8e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EGFR—malignant glioma	6.34e-06	2.78e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—AKT1—malignant glioma	6.32e-06	2.78e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	6.21e-06	2.73e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MYC—malignant glioma	6.21e-06	2.73e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CASP3—malignant glioma	6.16e-06	2.7e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL2—malignant glioma	6.15e-06	2.7e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—NCOR1—malignant glioma	6.1e-06	2.68e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.1e-06	2.68e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MMP9—malignant glioma	6.08e-06	2.67e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VEGFA—malignant glioma	6.07e-06	2.67e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EGFR—malignant glioma	6.07e-06	2.67e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	6.06e-06	2.66e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PTEN—malignant glioma	6.05e-06	2.65e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MDM2—malignant glioma	6.04e-06	2.65e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—RAF1—malignant glioma	6.02e-06	2.64e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—STAT3—malignant glioma	6.01e-06	2.64e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VEGFA—malignant glioma	5.99e-06	2.63e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—KRAS—malignant glioma	5.99e-06	2.63e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ERBB2—malignant glioma	5.95e-06	2.61e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—STAT3—malignant glioma	5.93e-06	2.61e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—AKT1—malignant glioma	5.9e-06	2.59e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	5.88e-06	2.58e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CAV1—malignant glioma	5.87e-06	2.58e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—AKT1—malignant glioma	5.83e-06	2.56e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CAV1—malignant glioma	5.82e-06	2.56e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MMP9—malignant glioma	5.82e-06	2.55e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CG—malignant glioma	5.82e-06	2.55e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PTEN—malignant glioma	5.78e-06	2.54e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PIK3CA—malignant glioma	5.74e-06	2.52e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—KRAS—malignant glioma	5.74e-06	2.52e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CXCL8—malignant glioma	5.65e-06	2.48e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—AKT1—malignant glioma	5.64e-06	2.48e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PPARG—malignant glioma	5.61e-06	2.46e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MYC—malignant glioma	5.59e-06	2.45e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.56e-06	2.44e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MYC—malignant glioma	5.51e-06	2.42e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—PIK3CA—malignant glioma	5.51e-06	2.42e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EGFR—malignant glioma	5.47e-06	2.4e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VEGFA—malignant glioma	5.46e-06	2.4e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	5.45e-06	2.39e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—STAT3—malignant glioma	5.41e-06	2.37e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CASP3—malignant glioma	5.4e-06	2.37e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL2—malignant glioma	5.4e-06	2.37e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EGFR—malignant glioma	5.39e-06	2.37e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.35e-06	2.35e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—malignant glioma	5.33e-06	2.34e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CG—malignant glioma	5.3e-06	2.33e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PIK3CA—malignant glioma	5.27e-06	2.31e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VEGFA—malignant glioma	5.22e-06	2.29e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—STAT3—malignant glioma	5.17e-06	2.27e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—KRAS—malignant glioma	5.16e-06	2.27e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PPARG—malignant glioma	5.16e-06	2.27e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PPARG—malignant glioma	5.12e-06	2.25e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CD—malignant glioma	5.11e-06	2.24e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MMP9—malignant glioma	5.11e-06	2.24e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—malignant glioma	5.1e-06	2.24e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—KRAS—malignant glioma	5.1e-06	2.24e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PTEN—malignant glioma	5.08e-06	2.23e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MYC—malignant glioma	5.02e-06	2.21e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CAV1—malignant glioma	4.98e-06	2.18e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—AKT1—malignant glioma	4.95e-06	2.17e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EGFR—malignant glioma	4.91e-06	2.16e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PIK3CA—malignant glioma	4.85e-06	2.13e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MYC—malignant glioma	4.81e-06	2.11e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.75e-06	2.09e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PIK3CA—malignant glioma	4.74e-06	2.08e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.7e-06	2.06e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EGFR—malignant glioma	4.7e-06	2.06e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—AKT1—malignant glioma	4.69e-06	2.06e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PIK3CA—malignant glioma	4.68e-06	2.06e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CD—malignant glioma	4.66e-06	2.05e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—KRAS—malignant glioma	4.64e-06	2.04e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—malignant glioma	4.59e-06	2.02e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VEGFA—malignant glioma	4.59e-06	2.01e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—STAT3—malignant glioma	4.54e-06	1.99e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CG—malignant glioma	4.53e-06	1.99e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—malignant glioma	4.53e-06	1.99e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PIK3CA—malignant glioma	4.52e-06	1.99e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—AKT1—malignant glioma	4.5e-06	1.97e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CB—malignant glioma	4.46e-06	1.96e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—KRAS—malignant glioma	4.44e-06	1.95e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTGS2—malignant glioma	4.42e-06	1.94e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PPARG—malignant glioma	4.37e-06	1.92e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—AKT1—malignant glioma	4.31e-06	1.89e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PIK3CA—malignant glioma	4.27e-06	1.87e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MYC—malignant glioma	4.22e-06	1.85e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EGFR—malignant glioma	4.13e-06	1.81e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—malignant glioma	4.13e-06	1.81e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CB—malignant glioma	4.1e-06	1.8e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	4.08e-06	1.79e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CB—malignant glioma	4.06e-06	1.78e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTGS2—malignant glioma	4.06e-06	1.78e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTGS2—malignant glioma	4.03e-06	1.77e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.98e-06	1.75e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—AKT1—malignant glioma	3.97e-06	1.74e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—malignant glioma	3.95e-06	1.73e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—KRAS—malignant glioma	3.9e-06	1.71e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—AKT1—malignant glioma	3.88e-06	1.7e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTEN—malignant glioma	3.85e-06	1.69e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—AKT1—malignant glioma	3.82e-06	1.68e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—AKT1—malignant glioma	3.7e-06	1.62e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	3.58e-06	1.57e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTEN—malignant glioma	3.54e-06	1.56e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTEN—malignant glioma	3.51e-06	1.54e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—AKT1—malignant glioma	3.48e-06	1.53e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.47e-06	1.52e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—malignant glioma	3.47e-06	1.52e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTGS2—malignant glioma	3.44e-06	1.51e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—AKT1—malignant glioma	3.33e-06	1.46e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTEN—malignant glioma	3e-06	1.32e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—AKT1—malignant glioma	2.93e-06	1.28e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.72e-06	1.19e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.5e-06	1.1e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.48e-06	1.09e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—AKT1—malignant glioma	2.22e-06	9.74e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CA—malignant glioma	2.12e-06	9.29e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—AKT1—malignant glioma	2.04e-06	8.96e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—AKT1—malignant glioma	2.02e-06	8.88e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—AKT1—malignant glioma	1.73e-06	7.59e-06	CbGpPWpGaD
